Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by Stanford University
Sponsor:
Collaborators:
The Leukemia and Lymphoma Society
Biospect Inc
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT00398177
First received: November 9, 2006
Last updated: February 12, 2014
Last verified: February 2014
  Purpose

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.


Condition
Lymphoma, Non-Hodgkin
Hodgkin's Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Collection of tumor tissue to characterize the molecular and cell biology of tumor cells in lymphoma. [ Time Frame: The study will continue indefinitely. ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

tumor tissue


Estimated Enrollment: 9999
Study Start Date: June 1999
Estimated Study Completion Date: June 2017
Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)
Detailed Description:

This research involves the study of lymphoma cells in order to better understand how the disease grows and spreads. This study may lead to the development of special materials that could be used, in the future, to treat lymphoma or to follow the response of lymphoma to treatment.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Any type of NHL or Hodgkin's disease.

Criteria

Inclusion Criteria:- Any type of NHL or Hodgkin's disease.

Exclusion Criteria:- Patients without NHL or Hodgkin's disease

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00398177

Contacts
Contact: Cancer Clinical Trials Office (650) 498-7061 ccto-office@stanford.edu

Locations
United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Cancer Clinical Trials Office    650-498-7061    ccto-office@stanford.edu   
Contact: Cancer Clinical Trials Office    (650) 498-7061    ccto-office@stanford.edu   
Principal Investigator: Ronald Levy         
Sub-Investigator: Gideon Gross         
Sub-Investigator: Shoshana Levy         
Sponsors and Collaborators
Stanford University
The Leukemia and Lymphoma Society
Biospect Inc
Investigators
Principal Investigator: Ronald Levy Stanford University
  More Information

No publications provided

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT00398177     History of Changes
Other Study ID Numbers: LYM0001, 76973, LYM0001, 13500
Study First Received: November 9, 2006
Last Updated: February 12, 2014
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hodgkin Disease
Lymphoma
Lymphoma, Non-Hodgkin
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases

ClinicalTrials.gov processed this record on July 24, 2014